Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-dense ABVD in early-stage unfavorable Hodgkin lymphoma
2011-003191-36Phase 2Completed
- Sponsor
- Fondazione Italiana Linfomi
- Start
- Mar 2012
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin, bleomycin, vinblastine, dacarbazine in Hodgkin lymphoma (HL), sponsored by Fondazione Italiana Linfomi. Started Mar 2012; status: completed.
02
Drugs
doxorubicinbleomycinvinblastinedacarbazine
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on 2011-003191-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003191-36.